From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
- Report
- June 2024
United States
From €938EUR$950USD£782GBP
- Report
- June 2024
United Kingdom
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
From €938EUR$950USD£782GBP
- Report
- June 2024
Turkey
From €938EUR$950USD£782GBP
- Report
- June 2024
Taiwan
From €938EUR$950USD£782GBP
- Report
- June 2024
Panama
From €938EUR$950USD£782GBP
- Report
- June 2024
Mexico
From €938EUR$950USD£782GBP
- Report
- June 2024
Kuwait
From €938EUR$950USD£782GBP
- Report
- June 2024
Jordan
From €938EUR$950USD£782GBP
In Vitro Diagnostics (IVD) is a medical technology used to diagnose diseases and conditions through the analysis of bodily fluids and tissues. It is used to detect, diagnose, and monitor diseases, as well as to assess the effectiveness of treatments. IVD tests are performed in laboratories, hospitals, and other healthcare settings.
IVD tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. They can also be used to monitor the progress of a disease or to assess the effectiveness of a treatment. IVD tests are used to detect and measure the presence of specific molecules, such as proteins, hormones, and enzymes, in a sample.
IVD tests are performed using a variety of technologies, including immunoassays, molecular diagnostics, and flow cytometry. These tests are used to diagnose a wide range of conditions, including infectious diseases, genetic disorders, and cancer.
Some of the major companies in the IVD market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more